Evidence map›Paper›PMID 35115054›Full record

ArticleMicrobiome2022

Species-targeted sorting and cultivation of commensal bacteria from the gut microbiome using flow cytometry under anaerobic conditions.

Samuel Bellais, Mélanie Nehlich, Maryne Ania, Aurore Duquenoy, Wilfrid Mazier, Ger van den Engh, Jan Baijer, Nicole Simone Treichel, Thomas Clavel, Ilia Belotserkovsky and 1 more

Abstract readVideo-Audio Media
In one paragraph

Article in Microbiome, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed.

  1. Article
  2. NovelGut · 2026
    Article
  3. Article
  4. Description ofInternational journal of systematic and evolutionary microbiology · 2026
    Article
  5. Article
  6. Potential and Challenges ofFoods (Basel, Switzerland) · 2025
    Review
  7. Article
  8. Review
  9. Complete genome sequence of twoMicrobiology resource announcements · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Complete genome sequence of twoMicrobiology resource announcements · 2024
    Article
  16. Microbial single-cell applications under anoxic conditions.Applied and environmental microbiology · 2024
    Review
  17. Review
  18. Review
  19. Article
  20. Research (Washington, D.C.) · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Samuel BellaisBIOASTER, 28 rue du Docteur Roux, 75015, Paris, France.
Mélanie NehlichBIOASTER, 28 rue du Docteur Roux, 75015, Paris, France.
Maryne AniaBIOASTER, 28 rue du Docteur Roux, 75015, Paris, France.
Aurore DuquenoyMaaT Pharma, Lyon, France.
Wilfrid MazierYSOPIA Bioscience, Bordeaux, France.
Ger van den EnghMarine Cytometry, Concrete, WA, 98237, USA.
Jan BaijerCommissariat à l'Energie Atomique et aux Energies Alternatives, Département de la Recherche Fondamentale, Institut de Biologie François Jacob, Institut de Radiobiologie Cellulaire et Moléculaire, Fontenay-aux-Roses, France.
Nicole Simone TreichelFunctional Microbiome Research Group, Institute of Medical Microbiology, University Hospital of RWTH, Aachen, Germany.
Thomas ClavelFunctional Microbiome Research Group, Institute of Medical Microbiology, University Hospital of RWTH, Aachen, Germany.
Ilia BelotserkovskyBIOASTER, 28 rue du Docteur Roux, 75015, Paris, France.
Vincent ThomasBIOASTER, 28 rue du Docteur Roux, 75015, Paris, France. vincent.thomas@bioaster.org.ORCID 0000-0003-4034-9525

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThere is a growing interest in using gut commensal bacteria as "next generation" probiotics. However, this approach is still hampered by the fact that there are few or no strains available for specific species that are difficult to cultivate. Our objective was to adapt flow cytometry and cell sorting to be able to detect, separate, isolate, and cultivate new strains of commensal species from fecal material. We focused on the extremely oxygen sensitive (EOS) species Faecalibacterium prausnitzii and the under-represented, health-associated keystone species Christensenella minuta as proof-of-concept.

resultsA BD Influx® cell sorter was equipped with a glovebox that covered the sorting area. This box was flushed with nitrogen to deplete oxygen in the enclosure. Anaerobic conditions were maintained during the whole process, resulting in only minor viability loss during sorting and culture of unstained F. prausnitzii strains ATCC 27766, ATCC 27768, and DSM 17677. We then generated polyclonal antibodies against target species by immunizing rabbits with heat-inactivated bacteria. Two polyclonal antibodies were directed against F. prausnitzii type strains that belong to different phylogroups, whereas one was directed against C. minuta strain DSM 22607. The specificity of the antibodies was demonstrated by sorting and sequencing the stained bacterial fractions from fecal material. In addition, staining solutions including LIVE/DEAD™ BacLight™ Bacterial Viability staining and polyclonal antibodies did not severely impact bacterial viability while allowing discrimination between groups of strains. Finally, we combined these staining strategies as well as additional criteria based on bacterial shape for C. minuta and were able to detect, isolate, and cultivate new F. prausnitzii and C. minuta strains from healthy volunteer's fecal samples.

conclusionsTargeted cell-sorting under anaerobic conditions is a promising tool for the study of fecal microbiota. It gives the opportunity to quickly analyze microbial populations, and can be used to sort EOS and/or under-represented strains of interest using specific antibodies, thus opening new avenues for culture experiments. Video abstract.

Indexed as

Gastrointestinal MicrobiomeAnaerobiosisAnimalsBacteriaFaecalibacterium prausnitziiFlow CytometryRabbitsAnaerobicChristensenellaCulturomicsFaecalibacteriumFlow cytometryMicrobiotaSorting

Identifiers

PMID35115054
PMCPMC8812257

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.